National Center for Complementary & Integrative Health; Notice of Closed Meeting, 58739-58740 [2015-24691]
Download as PDF
<![CDATA[
58739
Federal Register / Vol. 80, No. 189 / Wednesday, September 30, 2015 / Notices
When
submitting comments or requesting
information, please include the OMB
control number 0990–0281 for
reference.
Information Collection Request Title:
Prevention Communication Formative
Research—Revision—OMB No. 0990–
0281—Office of Disease Prevention and
Health Promotion.
Abstract: The Office of Disease
Prevention and Health Promotion’s
(ODPHP) focus includes developing and
disseminating prevention information to
the public. Changes in this request
include updated national hourly wage
and minor changes to data collection
activities and related burden hours in
order to meet the needs of the initiatives
mentioned below. This request builds
on previous formative research
approaches to place more emphasis on
Web-based data collection to allow
SUPPLEMENTARY INFORMATION:
greater geographical diversity among
respondents, to decrease respondent
burden, and to save government costs.
As a federal government agency, ODPHP
strives to be responsive to the needs of
America’s diverse audiences while
simultaneously serving all Americans
across a range of channels. To carry out
its prevention information efforts,
ODPHP is committed to conducting
formative and usability research to
provide guidance on the development
and implementation of its disease
prevention and health promotion
communication and education efforts.
This generic clearance request describes
data collection activities involving
methods such as: Individual interviews,
focus groups, Web-based surveys, card
sorting and various forms of usability
testing to establish a deeper
understanding of the interests and needs
of consumers and health professionals
for disease prevention and health
promotion information and tools.
The information collected will be
used by ODPHP to improve its
communication, products, and services
that support key office activities
including: Healthy People, Dietary
Guidelines for Americans, Physical
Activity Guidelines for Americans,
healthfinder.gov, and increasing health
care quality and patient safety. ODPHP
communicates through its Web sites
(www.healthfinder.gov,
www.HealthyPeople.gov,
www.health.gov) and through other
channels including social media, print
materials, interactive training modules,
and reports.
Likely Respondents: Respondents are
likely to be either consumers or health
professionals.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden/
response
(in hours)
Number of
responses/
respondent
Number of
respondents
Data collection task
Instrument/form name
In-depth interviews ......................................
Screener ..............................
Interview ..............................
Screener ..............................
Focus Group ........................
Screener ..............................
Survey ..................................
Screener ..............................
Card Sort .............................
Screener ..............................
135
45
240
80
6000
2000
180
60
360
1
1
1
1
1
1
1
1
1
Usability Test .......................
120
1
..............................................
........................
........................
Focus groups ...............................................
Web-based surveys .....................................
Card sorting .................................................
Usability and prototype testing of materials
(print and Web).
Total ......................................................
Terry S. Clark,
Asst Information Collection Clearance
Officer.
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2015–24702 Filed 9–29–15; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Heart, Lung, and Blood
Institute Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Sep<11>2014
18:27 Sep 29, 2015
Jkt 235001
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Clinical and Basic Science Review
Committee.
Date: October 22–23, 2015.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Westin Crystal City, 1800 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Keith A. Mintzer, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7186, Bethesda, MD 20892–7924, 301–594–
7947, mintzerk@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Total response
burden
(in hours)
10/60
1
10/60
1.5
5/60
15/60
10/60
1
10/60
22.5
45
40
120
500
500
180
60
60
1
..........................
120
1,647.50
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 24, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–24690 Filed 9–29–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
E:\FR\FM\30SEN1.SGM
30SEN1
58740
Federal Register / Vol. 80, No. 189 / Wednesday, September 30, 2015 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Clinical Research on
Natural Products (R21 AND R33).
Date: November 4, 2015.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD (Virtual Meeting).
Contact Person: Martina Schmidt, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Complementary,
& Integrative Health, NIH, 6707 Democracy
Blvd., Suite 401, Bethesda, MD 20892, 301–
594–3456, schmidma@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: September 24, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–24691 Filed 9–29–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Initial Review
VerDate Sep<11>2014
19:33 Sep 29, 2015
Jkt 235001
Group; Reproduction, Andrology, and
Gynecology Subcommittee.
Date: October 16, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Dennis E. Leszczynski,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20892–9304, (301) 435–6884, leszczyd@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: September 24, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–24689 Filed 9–29–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Motor Function, Speech and
Rehabilitation.
Date: October 21, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Mark Lindner, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, 301–915–
6298, mark.lindner@csr.nih.gov.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Radiation Therapeutics and Biology
Study Section.
Date: October 26–27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott—Courtyard Long Beach
Downtown, 500 East First Street, Long Beach,
CA 90802.
Contact Person: Bo Hong, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–14–
089: Alzheimer’s Disease Pilot Clinical
Trials.
Date: October 26, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Mark Lindner, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, 301–915–
6298, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 12–
251: Behavioral Science Track Award for
Rapid Transition Review.
Date: October 28, 2015.
Time: 2:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, (301) 455–
1761, kellya2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neural Trauma and Stroke.
Date: October 28, 2015.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Alexei Kondratyev, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, 301–435–
1785, kondratyevad@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\30SEN1.SGM
30SEN1
]]>Agencies
[Federal Register Volume 80, Number 189 (Wednesday, September 30, 2015)]
[Notices]
[Pages 58739-58740]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24691]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Integrative Health; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
[[Page 58740]]
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and
Integrative Health Special Emphasis Panel; Clinical Research on
Natural Products (R21 AND R33).
Date: November 4, 2015.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD (Virtual Meeting).
Contact Person: Martina Schmidt, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Center for
Complementary, & Integrative Health, NIH, 6707 Democracy Blvd.,
Suite 401, Bethesda, MD 20892, 301-594-3456, schmidma@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.213,
Research and Training in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: September 24, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-24691 Filed 9-29-15; 8:45 am]
BILLING CODE 4140-01-P
